J Neurocrit Care.  2019 Jun;12(1):64-65. 10.18700/jnc.190085.

Cerebral air embolism treated using hyperbaric oxygen therapy

• Kim YJ
• Jeon SB

• KMID: 2452829
• DOI: http://doi.org/10.18700/jnc.190085

Abstract

No abstract available.

MeSH Terms

Embolism, Air*
Hyperbaric Oxygenation*

Figure

• 

  Fig. 1. Computed tomography (CT) and magnetic resonance imaging (MRI) scans of the brain obtained before (upper row) and after (lower row) hyperbaric oxygen therapy (HBOT). (A) Initial CT scan showing multiple air emboli, predominantly in the right hemisphere. (B) Initial MRI scan showing multiple air emboli on susceptibility-weighted imaging, (C) acute infarcts on diffusion-weighted imaging, and (D) diffuse enhancement on T1-weighted contrast-enhanced imaging. The Glasgow Coma Scale score was 5 (eye opening, 2; motor response, 2; and verbal response, 1) when the initial MRI scan was obtained. (E) Follow-up CT scan obtained 80 minutes after HBOT showing disappearance of air emboli. (F) Follow-up MRI scan obtained 5 days after HBOT showing disappearance of air emboli on susceptibility-weighted imaging, (G) decrease in infarct size on diffusion-weighted imaging, and (H) resolution of diffuse enhancement on T1-weighted contrast-enhanced imaging. The Glasgow Coma Scale score was 14 (eye opening: 4, motor response: 6, and verbal response: 4) when the follow-up MRI scan was obtained. White arrows indicate air emboli, black arrows indicate acute infarcts, and white arrowheads indicate diffuse T1-enhancement.

Reference

1. Jeon SB, Kim JS, Lee DK, Kang DW, Kwon SU. Clinicoradiological characteristics of cerebral air embolism. Cerebrovasc Dis. 2007; 23:459–62.

2. Jeon SB, Kang DW. Cerebral air emboli on T2-weighted gradient-echo magnetic resonance imaging. J Neurol Neurosurg Psychiatry. 2007; 78:871.

3. Hjouj M, Last D, Guez D, Daniels D, Sharabi S, Lavee J, et al. MRI study on reversible and irreversible electroporation induced blood brain barrier disruption. PLoS One. 2012; 7:e42817.

4. Gill AL, Bell CN. Hyperbaric oxygen: its uses, mechanisms of action and outcomes. QJM. 2004; 97:385–95.